These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9682146)

  • 1. Pharmacokinetics of d-limonene in the rat by GC-MS assay.
    Chen H; Chan KK; Budd T
    J Pharm Biomed Anal; 1998 Aug; 17(4-5):631-40. PubMed ID: 9682146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas chromatographic-mass spectrometric analysis of d-limonene in human plasma.
    Wang S; Chen Y; Gao Z; Xiong M; Zhong Z; Ye L
    J Pharm Biomed Anal; 2007 Sep; 44(5):1095-9. PubMed ID: 17540528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content.
    Chow HH; Salazar D; Hakim IA
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1472-6. PubMed ID: 12433729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma.
    Zhang Z; Chen H; Chan KK; Budd T; Ganapathi R
    J Chromatogr B Biomed Sci Appl; 1999 May; 728(1):85-95. PubMed ID: 10379660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human metabolism of the experimental cancer therapeutic agent d-limonene.
    Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN
    Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of d-limonene in mice plasma and tissues by a new GC-MS/MS method: Comparison of the pharmacokinetics and tissue distribution by oral and inhalation administration in mice.
    Chen C; Sheng Y; Hu Y; Sun J; Li W; Feng H; Tang L
    Biomed Chromatogr; 2019 Jul; 33(7):e4530. PubMed ID: 30845345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method.
    Jin H; Gerber JP; Wang J; Ji M; Davey AK
    J Pharm Biomed Anal; 2008 Nov; 48(3):986-90. PubMed ID: 18701231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence evaluation of two D-limonene capsule formulations in healthy Chinese volunteers.
    Liu T; Guo Y; Gao Z; Chen Z; Jiang X
    Pharmazie; 2008 Oct; 63(10):718-20. PubMed ID: 18972832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS.
    Chan KK; Bakhtiar R; Jiang C
    Invest New Drugs; 1997; 15(3):195-206. PubMed ID: 9387042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of d-limonene in adipose tissue by gas chromatography-mass spectrometry.
    Miller JA; Hakim IA; Thomson C; Thompson P; Chow HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):68-73. PubMed ID: 18571481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and immune responses resulting from oral administration of D-limonene in rats.
    Hamada M; Uezu K; Matsushita J; Yamamoto S; Kishino Y
    J Nutr Sci Vitaminol (Tokyo); 2002 Apr; 48(2):155-60. PubMed ID: 12171437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-Limonene metabolism in humans and metabolite kinetics after oral administration.
    Schmidt L; Göen T
    Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
    Vigushin DM; Poon GK; Boddy A; English J; Halbert GW; Pagonis C; Jarman M; Coombes RC
    Cancer Chemother Pharmacol; 1998; 42(2):111-7. PubMed ID: 9654110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A; Fischer H; Römer A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and sensitive liquid chromatography-tandem mass spectrometric method for the determination of timosaponin B-II in blood plasma and a study of the pharmacokinetics of saponin in the rat.
    Cai F; Sun L; Gao S; Yang Y; Yang Q; Chen W
    J Pharm Biomed Anal; 2008 Dec; 48(5):1411-6. PubMed ID: 19027255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics and stability of isophosphoramide mustard.
    Zheng JJ; Chan KK; Muggia F
    Cancer Chemother Pharmacol; 1994; 33(5):391-8. PubMed ID: 8306413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of limonene oxidation products using SPME and GC-MS.
    Marine SS; Clemons J
    J Chromatogr Sci; 2003 Jan; 41(1):31-5. PubMed ID: 12597594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.
    Crowell PL; Lin S; Vedejs E; Gould MN
    Cancer Chemother Pharmacol; 1992; 31(3):205-12. PubMed ID: 1464157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical LC-MS/MS method development and validation of novel antidiabetic candidate S007-1261 in rat plasma and its application to pharmacokinetic and oral bioavailability studies.
    Misra A; Kushwaha HN; Gautam N; Singh B; Verma PC; Pratap R; Singh SK
    Drug Res (Stuttg); 2014 Aug; 64(8):399-405. PubMed ID: 24258707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.